These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24373398)

  • 1. [Analysis of risk factors for all cause-mortality in Chinese emergency atrial fibrillation patients].
    Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Huang B; Tian L
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2871-5. PubMed ID: 24373398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of risk factors for stroke in atrial fibrillation and hypertension patients].
    Wang J; Yang Y; Zhu J; Shao X; Zhang H; Li J; Liu L;
    Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):269-72. PubMed ID: 24857298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The impact of hypertension history and baseline blood pressure levels on the cardiovascular outcomes in Chinese emergency atrial fibrillation patients].
    Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Tian L; Huang B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):911-5. PubMed ID: 24370216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men.
    Roquer J; Rodríguez-Campello A; Gomis M; Ois A; Martínez-Rodríguez JE; Munteis E; Jiménez Conde J; Montaner J; Alvarez Sabín J
    J Neurol; 2006 Nov; 253(11):1484-9. PubMed ID: 16941081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.
    Zhang H; Yang Y; Zhu J; Shao X; Liu Y; Zhao L; Yu P; Zhang H; He Q; Gu X
    Intern Med J; 2014 Aug; 44(8):742-8. PubMed ID: 24893684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Guan N; Zhu Z; Kowey PR; Allen LA; Fonarow GC; Hylek EM; Mahaffey KW; Freeman JV; Chang P; Holmes DN; Peterson ED; Piccini JP; Gersh BJ;
    Am Heart J; 2015 May; 169(5):647-654.e2. PubMed ID: 25965712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
    Guize L; Thomas F; Bean K; Benetos A; Pannier B
    Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Stortecky S; Buellesfeld L; Wenaweser P; Heg D; Pilgrim T; Khattab AA; Gloekler S; Huber C; Nietlispach F; Meier B; Jüni P; Windecker S
    Circ Cardiovasc Interv; 2013 Feb; 6(1):77-84. PubMed ID: 23386662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.